OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies

HTML PDF

Year: 2022
Type: article
Source: Blood
DOI: 10.1182/blood.2022018283
Authors: James A. Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J. Gaffney, Mary McGann, Alyssa Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T. Hess
Institutions: Medical University of South Carolina, MUSC Hollings Cancer Center
Language: English

Topic: SARS-CoV-2 and COVID-19 Research
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: tixagevimab/cilgavimab, SARS-CoV-2, COVID-19 prevention, B-cell malignancies, chronic lymphocytic leukemia, B-cell lymphoma, multiple myeloma, B-cell acute lymphoblastic leukemia, pre-exposure prophylaxis, passive immunization, breakthrough infection, immunosuppression, COVID-19 vaccination
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W4308339823
FWCI: 6.892
Cites: 9
Cited by: 60
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security